EBCC 6: New chemotherapy combo produces side effects, but no extra efficacy, in early breast cancer patients.

Bookmark and Share
Published: 3 Dec 2008
Views: 13830
Rating:
Save
Professor Gunter von Minckwitz - Chairman of the German Breast Group
Prof. von Minckwitz discusses a trial investigating the use of capecitabine as a chemotherapeutic drug to treat breast cancer. This study did not show any incease in efficacy when capecitabine was used and did produce capecitabine specific toxicities.